Skip to main content
Clinical Trials/NCT06016491
NCT06016491
Completed
Not Applicable

The Effect of Acupressure on Menopausal Symptoms: A Randomized, Sham Controlled Study

Mersin University1 site in 1 country81 target enrollmentJuly 5, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Menopause
Sponsor
Mersin University
Enrollment
81
Locations
1
Primary Endpoint
Menopause Rating Scale (MRS)
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This is a prospective, randomized, placebo-controlled and single-blind study planned to determine the effect of acupressure application on menopausal symptoms.

The hypothesis of the study is that acupressure reduces women's menopausal symptoms.

Detailed Description

Menopause is a physiological process during which most women have difficulties and face many problems. Acupressure can be taught and used safely as an effective method to manage the symptoms that women experience during menopause. This study aims to determine the effect of acupressure on menopausal symptoms. The study has a prospective, randomized, sham-controlled, single-blind design. The research was conducted with 81 women (acupressure n=40, sham acupressure n=41) attending the "Menopause School" in a public hospital in Türkiye between July 05, 2021 and August 02, 2021. Both groups received acupressure application thrice a week for four weeks, 12 sessions in total. The data was obtained using a personal information form and a Menopause Rating Scale.

Registry
clinicaltrials.gov
Start Date
July 5, 2021
End Date
March 21, 2022
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Melek Yesil Bayulgen

Lecturer (Principal Investigator)

Mersin University

Eligibility Criteria

Inclusion Criteria

  • Able to speak and understand Turkish
  • No psychiatric illness
  • Natural menopause
  • Not on hormone replacement therapy
  • Women who volunteered to participate in the study and did not receive any integrated therapy were included.

Exclusion Criteria

  • Those who have undergone menopause with the surgical method
  • For lower extremity vascular disease, fracture, sprain or injury, diabetes, cardiovascular disease, thyroid disease, etc. with a diagnosis
  • Women who received any integrative therapy were not included in the study.

Outcomes

Primary Outcomes

Menopause Rating Scale (MRS)

Time Frame: Change from before implementation, 0th week and 4th week of practice

Menopause symptom rating scale was used to evaluate menopausal symptoms. The Turkish reliability and validity study was conducted by Can (2005). The scale consists of 11 items and 3 sub-dimensions. For each item, there are "0=None", "1=Mild", "2=Moderate", "3=Severe" and "4=Very Severe" options. Sub-dimensions of the scale; somatic complaints (items 1,2,3 and 11), psychological complaints (items 4,5,6 and 7), and urogenital complaints (items 8,9 and 10). The total score of the scale ranges from 0 to 44. The somatic complaints sub-dimension is scored between 0-16, the psychological complaints sub-dimension 0-16, and the urogenital complaints sub-dimension 0-12. An increase in the total score obtained from the scale indicates that the severity of the complaints increases and the quality of life is negatively affected.

Study Sites (1)

Loading locations...

Similar Trials